GENNEX LABORATORIES
|
The Current P/E Ratio of GENNEX LABORATORIES is 20.14.
Share Price | ₹15.3 | Jan 21,2025 |
Market Cap | ₹348.1 Cr | |
Earnings-TTM | ₹17.3 Cr | TTM-Consolidated Results |
Price/Earnings | 20.14x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GENNEX LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹348.1 Cr] as on Jan 21,2025
(/) Earnings [ ₹17.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 20.14x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay 20.14 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENNEX LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GENNEX LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of GENNEX LABORATORIES
PE Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.71x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 31.6x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 11.69x.
How does GENNEX LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GENNEX LABORATORIES | 17.29 | 20.14 | 348.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 37.96 | 422,715.0 |
CIPLA LTD | 4,485.22 | 25.70 | 115,271.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 19.88 | 107,511.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.07 | 99,189.5 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.13 | 154,460.0 |
MANKIND PHARMA LTD | 2,124.86 | 49.77 | 105,755.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.31 | 106,868.0 |
LUPIN LTD | 2,651.94 | 36.19 | 95,964.4 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.15 | 68,923.7 |
ABBOTT INDIA LTD | 1,284.66 | 45.72 | 58,733.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GENNEX LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.15x |
Max industry PE | 84.13x |
Median industry PE | 36.19x |
Average industry PE | 38.27x |
You may also like the below Video Courses